Nandrolone 200 mg/ml Injection — Class II drug recall D-0166-2016
Terminated recall by Pacific Healthcare, Inc dba B&B Pharmacy, reported 2015-11-18, distributed in CA, NJ. Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality
| Recall number | D-0166-2016 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Pacific Healthcare, Inc dba B&B Pharmacy, Bellflower, CA, United States |
| Recall initiated | 2015-10-07 |
| Classified | 2015-11-10 |
| Reported by FDA | 2015-11-18 |
| Terminated | 2016-04-07 |
| Distributed | CA, NJ |
| Reason classes | sterility, cgmp |
| Expiration dates | 2015-10-23 |
Product
Nandrolone 200 mg/ml Injection, 10 mL and 20 mL vials, Rx, B & B Health Mart Pharmacy, Bellflower, CA
Reason for recall
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0166-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.